rs121909734
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_005271.5(GLUD1):c.1496G>T(p.Gly499Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 14/23 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G499C) has been classified as Pathogenic.
Frequency
Consequence
NM_005271.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hyperinsulinism-hyperammonemia syndrome Pathogenic:3
This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 499 of the GLUD1 protein (p.Gly499Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with familial hyperinsulinism (PMID: 10871207, 35951311). In at least one individual the variant was observed to be de novo. This variant is also known as GDH-G446V. ClinVar contains an entry for this variant (Variation ID: 226111). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects GLUD1 function (PMID: 32143698). This variant disrupts the p.Gly499 amino acid residue in GLUD1. Other variant(s) that disrupt this residue have been observed in individuals with GLUD1-related conditions (PMID: 9571255, 10871207, 18928469, 19046187, 30352420), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
- -
Pathogenic mutations in the GLUD1 gene are known to cause the hyperinsulinism-hyperammonemia syndrome. Another variant in the same codon (p.(Gly499Ser)) has been reported to cause the same pathology. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at